Image
Image
laph103-banner-speaking-companies-logos-tablet-01.png
laph103-banner-speaking-companies-logos-desktop-01.png
laph103-banner-speaking-companies-logos-phone-01.png

Partners

Who will
you meet?

More than:

 

0
Participants
0
Companies

Directors

VP's

CEO's

COO's

Bio-technologists

Managing Directors

Managers and Specialists

From these areas:

  • Biosimilars
  • Biobetters
  • Biotechnology
  • Biotherapeutics
  • Analytical science
  • Regulatory compliance
  • Quality Control
  • Clinical immunology
  • Scientific Affairs
  • Pharmacovigilance

Speakers

Julio Sánchez y Tépoz

Julio Sánchez y Tépoz

COFEPRIS, Mexico. Federal Commissioner Read More
William Dib

William Dib

ANVISA, Brazil. President Read More
Adilson Montaneira

Adilson Montaneira

Pfizer, Brazil. Business Unit Head - Biosimilars Read More
Jaime Uribe

Jaime Uribe

PROBIOMED, Mexico. CEO Read More
Martin Blüggel

Martin Blüggel

Protagen Protein Services, Germany. CEO Read More
  • 1
  • 2
  • 3
  • 4

USD 896  USD 1096

Until August 31st

Until September 30th

USD 996  USD 1196

USD1196  USD 1296

Until October 31st

Until November 14th

USD 1296  USD 1496

Programme at a Glance

LATAM Regulations Update
By Anvisa and Coferpis
How Biosimilars are being developed in Latam
Clinical Trials required for Biosimilars?
Biosimilars, The Mexican Industry Approach
Clinical Research and the Registration of Biosimilars
Interview: Industry Leaders and Their Strategy to Increase Biosimilar’s Access in the Region
Full programme in the PDF Agenda

Highlights from 2017

Keep me updated



About "JackLeckerman"

JackLeckerman Company has been established as a business intelligence event services and the promotion of global summits, strategic conferences, open forums and professional training.

©2018 JackLeckerman. All Rights Reserved. Designed By

Search